Drug Shortage Report for TRI-CIRA LO 21
Report ID | 36429 |
Drug Identification Number | 02401967 |
Brand name | TRICIRA LO |
Common or Proper name | NORGESTIMATE/ETHINYL ESTRADIOL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL NORGESTIMATE NORGESTIMATE NORGESTIMATE |
Strength(s) | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 21 BLS |
ATC code | G03AB |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-15 |
Estimated end date | 2018-03-09 |
Actual end date | 2018-02-19 |
Shortage status | Resolved |
Updated date | 2018-02-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-01-18 | English | Compare |
v2 | 2018-01-18 | French | Compare |
v3 | 2018-02-09 | English | Compare |
v4 | 2018-02-09 | French | Compare |
v5 | 2018-02-23 | English | Compare |
v6 | 2018-02-23 | French | Compare |
Showing 1 to 6 of 6